Literature DB >> 20931672

Dermoscopy as a diagnostic tool in demodicidosis.

Rina Segal1, Daniel Mimouni, Hanna Feuerman, Odelya Pagovitz, Michael David.   

Abstract

BACKGROUND: The in vivo demonstration of Demodex infestation is traditionally based on the microscopic identification of Demodex mites, which is time consuming and requires specific equipment and a trained observer.
OBJECTIVE: The aim of this study was to describe for the first time the use of polarized-light dermoscopy for the diagnosis of demodicidosis in patients with variable clinical presentations.
METHODS: A total of 72 patients with variable facial eruptions were examined clinically, microscopically, and dermoscopically for the presence of Demodex mites.
RESULTS: Of the 72 patients, 55 were found to have demodicidosis. In 54 patients, the dermoscopy examination yielded a specific picture consisting of Demodex "tails" and Demodex follicular openings. In patients with an inflammatory variant of demodicidosis, reticular horizontal dilated blood vessels were also visualized. Microscopically, skin scrapings demonstrated Demodex in 52 patients. Overall, the dermoscopy findings showed excellent agreement with the microscopy findings (kappa value 0.86, 95% CI 0.72–0.99, P < 0.001). In the remaining 17 patients, there was no evidence of Demodex infestation either microscopically or dermoscopically. LIMITATIONS: The study was not blinded. As there are no standards for the diagnosis of demodicidosis, our results were based on criteria developed by our research group.
CONCLUSIONS: This is the first description of the specific dermoscopic findings associated with variable clinical presentations of demodicidosis. Dermoscopy may serve as a valuable tool for the real-time validation of Demodex infestation and the evaluation and follow-up of affected patients.

Entities:  

Mesh:

Year:  2010        PMID: 20931672     DOI: 10.1111/j.1365-4632.2010.04495.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  14 in total

1.  Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

2.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

3.  Dermoscopic Features of a Case of Lupus Miliaris Disseminatus Faciei.

Authors:  Biswanath Behera; Madhusmita Sethy; Ashish Kumar Nayak
Journal:  Indian Dermatol Online J       Date:  2021-02-01

4.  Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): An Up-to-Date Overview.

Authors:  Enzo Errichetti
Journal:  Dermatol Pract Concept       Date:  2019-07-31

5.  Scale and Pustule on Dermoscopy of Rosacea: A Diagnostic Clue for Demodex Species.

Authors:  Gamze Serarslan; Özlem Makbule Kaya; Emre Dirican
Journal:  Dermatol Pract Concept       Date:  2021-01-29

Review 6.  Vascular structures in dermoscopy.

Authors:  Erhan Ayhan; Derya Ucmak; ZeynepMeltem Akkurt
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

Review 7.  Dermoscopy in General Dermatology: A Practical Overview.

Authors:  Enzo Errichetti; Giuseppe Stinco
Journal:  Dermatol Ther (Heidelb)       Date:  2016-09-09

8.  Granulomatous rosacea: a case report.

Authors:  A Kelati; F Z Mernissi
Journal:  J Med Case Rep       Date:  2017-08-20

Review 9.  Human Permanent Ectoparasites; Recent Advances on Biology and Clinical Significance of Demodex Mites: Narrative Review Article.

Authors:  Dorota Litwin; WenChieh Chen; Ewa Dzika; Joanna Korycińska
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

10.  Dermoscopic Findings of Rosacea and Demodicosis.

Authors:  Yesim Akpinar Kara; Hatice Kaya Özden
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.